30 Apr 2024
Thank you to #target2patient for giving us the opportunity to present. The team found the conference fascinating and the future of research is bright 💡
2
1,522
29 Apr 2024
Very grateful to the #Target2Patient conference for supporting us and giving us an opportunity to present the Foundation and our Discovery Network. Lots of exciting interactions and engagement, and great speakers: the present and future of target discovery looks bright! @emblebi
29 Apr 2024
It's great to have our research team at the Target to Patient Conference today, presenting My Name’5 Doddie Foundation's Discovery Network
The Discovery Network has been launched to catalyse the search for effective MND treatments
To find out more visit: myname5doddie.co.uk/research…
4
231
4 weeks and counting until #Target2Patient 2024, and we are delighted to welcome our new event sponsor @UltimaGenomics.
In person registration closes 15 April 2024: ebi.ac.uk/targettopatient?ut…
#drugdiscovery #genomics #invitro technologies #AIML #digitalhealth #drugdevelopment
ALT Target to Patient conference logo
1
1
8
2,526
Introducing our keynote speakers at #Target2Patient, 29 – 30 April 2024: Dr Melanie Lee CBE, and Professor Sir Munir Pirmohamed @MPUoL.
Early bird registration is open until 26 February: ebi.ac.uk/targettopatient?ut…
#genomics, #invitro technologies, #digitalhealth #drugdevelopment
2
2
5
2,885
23 Jan 2024
Early bird discount is now available for #Target2Patient; run by our Industry Programme colleagues but open to all.
Full details in the post below.
Early bird registration is now open for #Target2Patient 2024.
Join us at @HinxtonHall, or online, to hear about the latest advances in #genomics, in vitro technologies, #AIML and digital health for drug development.
📆 29-30 April 2024
ebi.ac.uk/targettopatient/?u…
ALT Target 2 Patient conference registration details. 29-30 April 2024.
1
1,070
Early bird registration is now open for #Target2Patient 2024.
Join us at @HinxtonHall, or online, to hear about the latest advances in #genomics, in vitro technologies, #AIML and digital health for drug development.
📆 29-30 April 2024
ebi.ac.uk/targettopatient/?u…
ALT Target 2 Patient conference registration details. 29-30 April 2024.
1
6
12
5,045
12 Dec 2023
It's back! Join our Industry Programme's team for the #Target2Patient Conference 2024.
Early bird registration opens in the new year. Sign up for alerts and be the first to hear when registrations open: mailchi.mp/ebi/t2p24
Save the date for #Target2Patient Conference 2024!
The latest on advances in #genomics, in vitro technologies, #AIML and digital health for drug development.
📆 29-30 April 2024
Register your interest:
ebi.ac.uk/targettopatient?ut…
4
1,150
Save the date for #Target2Patient Conference 2024!
The latest on advances in #genomics, in vitro technologies, #AIML and digital health for drug development.
📆 29-30 April 2024
Register your interest:
ebi.ac.uk/targettopatient?ut…
2
3
5
3,084
11 May 2022
Was absolutely fabulous feeling the buzz of face-to-face events this week, and what a brilliant conference! #target2patient
2
10 May 2022
What a great conference #target2patient ! Fantasy talks and interactions F2F, and a beautiful venue surrounded by green and peace. Thanks!
1
2
10 May 2022
That's a wrap! It started with an idea four years ago. Delayed by the pandemic, but now completed, it was certainly worth the wait.
A big thank you to the venue, sponsors, organisers, speakers, and the audience both in-person & virtually that has joined us for #Target2Patient!
ALT A banner saying thank you stands in the grounds of the Hinxton Hall garden surrounded by purple irises.
2
5
12
10 May 2022
We're wrapping up at @emblebi #Target2Patient with our final keynote delivered by @RuthMcKernan from SV Health Investors. Ruth is presenting her talk looking from the patient to target and beyond.
ALT Patient to target and beyond. Ruth McKernan.
1
3
5
10 May 2022
Sandeep Menon from @pfizer is our second speaker for session four. He's presenting his work from the clinic to the hybrid #Target2Patient audience.
ALT Achieving end-to-end success in the clinic. Sandeep Menon.
1
2
5
10 May 2022
Session four is underway now at #Target2Patient beginning with Darren Plant from @FBMH_UoM speaking remotely. The session is focused on appropriate patients in the right trials.
🗣️Darren is presenting his work on the search for reliable #biomarkers.
ALT The search for reliable biomarkers of treatment response in rheumatoid arthritis. Darren Plant, University of Manchester.
1
2
6
10 May 2022
🧑💼The #Target2Patient hybrid poster session is now live! Delegates can talk to poster authors either in person at @HinxtonHall or online via wonder.me
ALT A screenshot of eight scientific posters.
1
1
4
10 May 2022
Our final speaker for #Target2Patient session three is Michael Johnson @imperialcollege detailing his work on #singlecell Mendelian randomisation for target discovery in brain disease.
ALT Single-cell Mendelian randomisation for target discovery in brain disease. Michael Johnson, Imperial College.
1
2
5
10 May 2022
Session three focusses on #bioinformatics and #BigData at #Target2Patient.
🗣️ It continues now with James Pilling from @ASTRAZENECAUK introducing the work of the @broadinstitute JUMP-CP consortium on morphological profiling.
ALT Accelerating drug discovery with images: the JUMP-CP consortium. James Pilling, AstraZeneca
1
5
7
10 May 2022
Next up is @emblebi's own @ewanbirney discussing using #genetics to understand human biology at #Target2Patient
ALT Using genetics to understand human biology. Ewan Birney, EMBL-EBI.
1
1
3